Kunming lantern show set to dazzle park visitors

<img src='https://news.cgtn.com/news/2024-02-01/Kunming-lantern-show-set-to-dazzle-park-visitors-1qQ3fhACZ7G/img/2232a722fc3749a0b9cbdddbb785c0d1/2232a722fc3749a0b9cbdddbb785c0d1.jpeg'A photo shows a blue dragon lantern in Daguan Park, Kunming, southwest China’s Yunnan Province, on January 31, 2024. /CFP <img src='https://news.cgtn.com/news/2024-02-01/Kunming-lantern-show-set-to-dazzle-park-visitors-1qQ3fhACZ7G/img/2232a722fc3749a0b9cbdddbb785c0d1/2232a722fc3749a0b9cbdddbb785c0d1.jpeg'A photo shows a blue dragon lantern in Daguan Park, Kunming, southwest China’s Yunnan Province, on January 31, 2024. /CFP <img src='https://news.cgtn.com/news/2024-02-01/Kunming-lantern-show-set-to-dazzle-park-visitors-1qQ3fhACZ7G/img/2232a722fc3749a0b9cbdddbb785c0d1/2232a722fc3749a0b9cbdddbb785c0d1.jpeg'A photo shows a blue dragon lantern in Daguan Park, Kunming, southwest…

Read More

Sage’s cognition drug fails in Parkinson’s study

An experimental drug designed to improve brain function in people with nerve-degrading disorders has failed a mid-stage study that tested it against Parkinson’s disease. The trial enrolled almost 90 participants, who once a day were given either a placebo or a drug from Sage Therapeutics called SAGE-718. Summary results released Wednesday showed no significant difference…

Read More

Apple’s Biggest AI Challenge? Making It Behave

Giannandrea said that Apple had focused on reducing hallucinations in its models partly by using curated data. “We have put considerable energy into training these models very carefully,” he said. “So we’re pretty confident that we’re applying this technology responsibly.” That training wheels approach to AI applies across Apple’s offering. If it works as promised,…

Read More